RARE: Wutah pendapatan kuartal marang kuartal Ultragenyx Corp

Logo grafis ultragenyx.com (RARE)

Ultragenyx Pharmaceutical specializes in therapies for rare genetic pathologies. The QoQ revenue growth percentage illustrates a strategy of minimizing capital expenditures by outsourcing production to third-party CMOs. Diversified international supply chains ensure the preservation of high-value drugs. Contract marketing and outsourced trials accelerate the implementation of innovations. The value of 7.90 shows the current level of this metric.

RARE (Ultragenyx Pharmaceutical Inc.) riwayat Tambahing pendapatan triwulanan saka 04.07.2022 nganti 21.11.2026

Rincian analitis perusahaan Ultragenyx Pharmaceutical Inc. (RARE)

Analisis wiwitan perusahaan:Ultragenyx Corp (RARE)
Produk seri Ultragenyx

This indicator measures the dynamics of quarterly inflows, neutralizing market volatility to identify the actual expansion rates of the operating cash flow. The current quarterly revenue growth rate 7.90 allows investors to assess the effectiveness of the commercial rollout of drugs for rare pathologies and confirm the sustainability of the portfolio scaling strategy of Ultragenyx Pharmaceutical (RARE) during the stage of active market niche capture.

Pesaing Ultragenyx Pharmaceutical (RARE)

TEM - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal qiagen.com QGEN|IONS: Wutah pendapatan triwulanan|Repligen Corp - Tambahing pendapatan triwulanan|RNA (Avidity Corp) - Wutah pendapatan triwulanan|CRISPR Therapeutics Corp - Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal genedx.com (WGS)|Owah-owahan dodolan kuartal marang kuartal BEAM|Wutah pendapatan triwulanan SRPT (Sarepta Corp)|TWST - Wutah dodolan triwulanan|TXG: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Intellia Therapeutics|STOK: Wutah pendapatan triwulanan|BLFS - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan WVE|MAZE: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Sionna Corp (SION)|Tingkat wutah dodolan sajrone kuartal Prime Medicine Bio|Wutah pendapatan triwulanan TSHA (Taysha Gene Therapies Inc)|Wutah pendapatan triwulanan uniqure.com QURE|MeiraGTx Holdings - Wutah pendapatan triwulanan|RGNX - Wutah pendapatan triwulanan|SLDB (Solid Corp) - Wutah dodolan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Ocugen Corp OCGN|PACB (Pacific Biosciences) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BNTC|Wutah pendapatan triwulanan DSGN|Wutah dodolan triwulanan Rocket Pharma RCKT|Tingkat wutah dodolan sajrone kuartal FDMT|Wutah pendapatan triwulanan Lexeo Therapeutics LXEO|KRRO - Wutah pendapatan kuartal marang kuartal|EDIT (Editas Medicine, Inc.) - Wutah dodolan kuartal marang kuartal|SLN: Wutah pendapatan triwulanan|ProQR - Tambahing pendapatan triwulanan|CDXS (Codexis) - Wutah pendapatan triwulanan|Sangamo (SGMO) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan NAUT|Wutah dodolan triwulanan Metagenomi, Inc. MGX|Wutah pendapatan kuartal marang kuartal Precision BioSciences DTIL|Tambahing pendapatan triwulanan GBIO|BOLD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Wutah pendapatan kuartal marang kuartal|RXi Pharmaceuticals - Tambahing pendapatan triwulanan|MBIO (Mustang Bio) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal RNAZ (transcodetherapeutics.com)|Wutah pendapatan kuartal marang kuartal Bionano (BNGO)|Applied DNA Sciences - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Tingkat wutah pendapatan sajrone kuartal|omegatherapeutics.com - Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Singular Genomics Systems Inc (OMIC)|RGLS: Wutah pendapatan triwulanan|Syros Pharmaceuticals, Inc (SYRS) - Wutah pendapatan triwulanan|TBIO (telesisbio.com) - Wutah pendapatan triwulanan|TCON: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Unity Biotechnology, Inc (UBX)